Literature DB >> 34362193

Current and Prospective Treatment of Adenomyosis.

Fady I Sharara1,2, Mira H Kheil3, Anis Feki4, Sara Rahman1, Jordan S Klebanoff5, Jean Marc Ayoubi6,7, Gaby N Moawad1.   

Abstract

(1) Background: Adenomyosis is a poorly understood entity which makes it difficult to standardize treatment. In this paper we review and compare the currently approved medical and surgical treatments of adenomyosis and present the evidence behind them. (2)
Methods: A PubMed search was conducted to identify papers related to the different treatments of adenomyosis. The search was limited to the English language. Articles were divided into medical and surgical treatments. (3)
Results: Several treatment options have been studied and were found to be effective in the treatment of adenomyosis. (4) Conclusions: Further randomized controlled trials are needed to compare treatment modalities and establish a uniform treatment algorithm for adenomyosis.

Entities:  

Keywords:  adenomyosis; fertility; medical treatment; surgical treatment

Year:  2021        PMID: 34362193     DOI: 10.3390/jcm10153410

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

Review 1.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

2.  Antiangiogenic Therapy as a New Strategy in the Treatment of Endometriosis? The First Case Report.

Authors:  Jean Bouquet de Joliniere; Arrigo Fruscalzo; Fathi Khomsi; Emanuela Stochino Loi; Floryn Cherbanyk; Jean Marc Ayoubi; Anis Feki
Journal:  Front Surg       Date:  2021-12-06

3.  Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy.

Authors:  Maria Sztachelska; Donata Ponikwicka-Tyszko; Lydia Martínez-Rodrigo; Piotr Bernaczyk; Ewelina Palak; Weronika Półchłopek; Tomasz Bielawski; Sławomir Wołczyński
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.